Your browser doesn't support javascript.
loading
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion.
Bass, Adam J; Lawrence, Michael S; Brace, Lear E; Ramos, Alex H; Drier, Yotam; Cibulskis, Kristian; Sougnez, Carrie; Voet, Douglas; Saksena, Gordon; Sivachenko, Andrey; Jing, Rui; Parkin, Melissa; Pugh, Trevor; Verhaak, Roel G; Stransky, Nicolas; Boutin, Adam T; Barretina, Jordi; Solit, David B; Vakiani, Evi; Shao, Wenlin; Mishina, Yuji; Warmuth, Markus; Jimenez, Jose; Chiang, Derek Y; Signoretti, Sabina; Kaelin, William G; Spardy, Nicole; Hahn, William C; Hoshida, Yujin; Ogino, Shuji; DePinho, Ronald A; Chin, Lynda; Garraway, Levi A; Fuchs, Charles S; Baselga, Jose; Tabernero, Josep; Gabriel, Stacey; Lander, Eric S; Getz, Gad; Meyerson, Matthew.
Afiliação
  • Bass AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Lawrence MS; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Brace LE; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Ramos AH; Broad Institute, Cambridge, Massachusetts, USA.
  • Drier Y; Broad Institute, Cambridge, Massachusetts, USA.
  • Cibulskis K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Sougnez C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Voet D; Broad Institute, Cambridge, Massachusetts, USA.
  • Saksena G; Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel.
  • Sivachenko A; Broad Institute, Cambridge, Massachusetts, USA.
  • Jing R; Broad Institute, Cambridge, Massachusetts, USA.
  • Parkin M; Broad Institute, Cambridge, Massachusetts, USA.
  • Pugh T; Broad Institute, Cambridge, Massachusetts, USA.
  • Verhaak RG; Broad Institute, Cambridge, Massachusetts, USA.
  • Stransky N; Broad Institute, Cambridge, Massachusetts, USA.
  • Boutin AT; Broad Institute, Cambridge, Massachusetts, USA.
  • Barretina J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Solit DB; Broad Institute, Cambridge, Massachusetts, USA.
  • Vakiani E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Shao W; Broad Institute, Cambridge, Massachusetts, USA.
  • Mishina Y; Broad Institute, Cambridge, Massachusetts, USA.
  • Warmuth M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Jimenez J; Broad Institute, Cambridge, Massachusetts, USA.
  • Chiang DY; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Signoretti S; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Kaelin WG; Novartis Institute of Biomedical Research, Cambridge, Massachusetts, USA.
  • Spardy N; Novartis Institute of Biomedical Research, Cambridge, Massachusetts, USA.
  • Hahn WC; Novartis Institute of Biomedical Research, Cambridge, Massachusetts, USA.
  • Hoshida Y; Department of Medical Oncology, Hospital Vall d'Hebron, Passeig Vall d'Hebron, Barcelona, Spain.
  • Ogino S; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • DePinho RA; Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
  • Chin L; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Garraway LA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Fuchs CS; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Baselga J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Tabernero J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Gabriel S; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Lander ES; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Getz G; Broad Institute, Cambridge, Massachusetts, USA.
  • Meyerson M; Broad Institute, Cambridge, Massachusetts, USA.
Nat Genet ; 43(10): 964-968, 2011 Sep 04.
Article em En | MEDLINE | ID: mdl-21892161
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Proteínas de Fusão Oncogênica / Proteínas Qb-SNARE / Proteína 2 Semelhante ao Fator 7 de Transcrição Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2011 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Proteínas de Fusão Oncogênica / Proteínas Qb-SNARE / Proteína 2 Semelhante ao Fator 7 de Transcrição Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2011 Tipo de documento: Article